The nuclear epidermal growth factor receptor (EGFR) function was also associated with (I) poor patient survival in breast cancer patients and (II) with increased local recurrence in oropharyngeal squamous cell cancer [31], [32]. The gene discussed is EGFR; the disease is breast carcinoma.